Plasmodium falciparum in Aotus nancymaae: A New Model for Placental Malaria

J Infect Dis. 2022 Aug 26;226(3):521-527. doi: 10.1093/infdis/jiac096.

Abstract

Plasmodium falciparum-infected erythrocytes that display the variant surface antigen VAR2CSA bind chondroitin sulfate A (CSA) to sequester in placental intervillous spaces, causing severe sequelae for mother and offspring. Here, we establish a placental malaria (PM) monkey model. Pregnant Aotus infected with CSA-binding P. falciparum CS2 parasites during the third trimester developed pronounced sequestration of late-stage parasites in placental intervillous spaces that express VAR2CSA and bind specifically to CSA. Similar to immune multigravid women, a monkey infected with P. falciparum CS2 parasites over successive pregnancies acquired antibodies against VAR2CSA, with potent functional activity that was boosted upon subsequent pregnancy infections. Aotus also developed functional antibodies after multiple acute PM episodes and subsequent VAR2CSA immunization. In summary, P. falciparum infections in pregnant Aotus monkeys recapitulate all the prominent features of human PM infection and immunity, and this model can be useful for basic mechanistic studies and preclinical studies to qualify candidate PM vaccines. Clinical Trials Registration: NCT02471378.

Keywords: Aotus monkey; Plasmodium falciparum; VAR2CSA; animal model; placental malaria.

Publication types

  • Clinical Study
  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Antibodies, Protozoan
  • Antigens, Protozoan
  • Aotidae
  • Chondroitin Sulfates
  • Erythrocytes
  • Female
  • Humans
  • Malaria*
  • Malaria, Falciparum*
  • Placenta
  • Plasmodium falciparum
  • Pregnancy
  • Pregnancy Complications, Parasitic*

Substances

  • Antibodies, Protozoan
  • Antigens, Protozoan
  • Chondroitin Sulfates

Associated data

  • ClinicalTrials.gov/NCT02471378